Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit von Ning, Wenjuan, Marti, Thomas M., Dorn, Patrick, Peng, Ren-Wang

Volltext

Fibrosis in PCLS: comparing TGF-β and fibrotic cocktail von Machahua, Carlos, Marti, Thomas M, Dorn, Patrick, Funke-Chambour, Manuela

Volltext

Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin von Shi, Yandong, Felley-Bosco, Emanuela, Marti, Thomas M, Orlowski, Katrin, Pruschy, Martin, Stahel, Rolf A

Volltext

Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro von Zeinali, Soheila, Bichsel, Colette A., Hobi, Nina, Funke, Manuela, Marti, Thomas M., Schmid, Ralph A., Guenat, Olivier T., Geiser, Thomas

Volltext

A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids von Ruppen, Janine, Cortes-Dericks, Lourdes, Marconi, Emanuele, Karoubi, Golnaz, Schmid, Ralph A, Peng, Renwang, Marti, Thomas M, Guenat, Olivier T

Volltext

H2AX Phosphorylation within the G₁ Phase after UV Irradiation Depends on Nucleotide Excision Repair and Not DNA Double-Strand Breaks von Marti, Thomas M., Hefner, Eli, Feeney, Luzviminda, Natale, Valerie, Cleaver, James E.

Volltext

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study von Guler, Sabina A, Machahua, Carlos, Geiser, Thomas K, Kocher, Gregor, Marti, Thomas M, Tan, Benjamin, Trappetti, Verdiana, Ryerson, Christopher J, Funke-Chambour, Manuela

Volltext

Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection von Brügger, Melanie, Démoulins, Thomas, Barut, G. Tuba, Zumkehr, Beatrice, Oliveira Esteves, Blandina I., Mehinagic, Kemal, Haas, Quentin, Schögler, Aline, Rameix-Welti, Marie-Anne, Eléouët, Jean-François, Moehrlen, Ueli, Marti, Thomas M., Schmid, Ralph A., Summerfield, Artur, Posthaus, Horst, Ruggli, Nicolas, Hall, Sean R. R., Alves, Marco P.

Volltext

mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer von Liang, Shun-Qing, Bührer, Elias D., Berezowska, Sabina, Marti, Thomas M., Xu, Duo, Froment, Laurène, Yang, Haitang, Hall, Sean R. R., Vassella, Erik, Yang, Zhang, Kocher, Gregor J., Amrein, Michael A., Riether, Carsten, Ochsenbein, Adrian F., Schmid, Ralph A., Peng, Ren-Wang

Volltext

A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip von Sengupta, Arunima, Dorn, Aurélien, Jamshidi, Mohammad, Schwob, Magali, Hassan, Widad, De Maddalena, Lea Lara, Hugi, Andreas, Stucki, Andreas O, Dorn, Patrick, Marti, Thomas M, Wisser, Oliver, Stucki, Janick D, Krebs, Tobias, Hobi, Nina, Guenat, Olivier T

Volltext

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment von Gao, Yanyun, Dorn, Patrick, Liu, Shengchen, Deng, Haibin, Hall, Sean R R, Peng, Ren-Wang, Schmid, Ralph A, Marti, Thomas M

Volltext

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer von Yang, Zhang, Liang, Shun‐Qing, Saliakoura, Maria, Yang, Haitang, Vassella, Eric, Konstantinidou, Georgia, Tschan, Mario, Hegedüs, Balazs, Zhao, Liang, Gao, Yanyun, Xu, Duo, Deng, Haibin, Marti, Thomas M, Kocher, Gregor J, Wang, Wenxiang, Schmid, Ralph A, Peng, Ren‐Wang

Volltext

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer von Yang, Zhang, Liang, Shun-Qing, Zhao, Liang, Yang, Haitang, Marti, Thomas M, Hegedüs, Balazs, Gao, Yanyun, Zheng, Bin, Chen, Chun, Wang, Wenxiang, Dorn, Patrick, Kocher, Gregor J, Schmid, Ralph A, Peng, Ren-Wang

Volltext

Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients von Lipp, Jesse J., Wang, Limei, Yang, Haitang, Yao, Feng, Harrer, Nathalie, Müller, Stefan, Berezowska, Sabina, Dorn, Patrick, Marti, Thomas M., Schmid, Ralph A., Hegedüs, Belazs, Souabni, Abdallah, Carotta, Sebastian, Pearson, Mark A., Sommergruber, Wolfgang, Kocher, Greg J., Hall, Sean R.R.

Volltext

MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma von Yang, Haitang, Gao, Yanyun, Xu, Duo, Xu, Ke, Liang, Shun-Qing, Yang, Zhang, Scherz, Amina, Hall, Sean R. R., Forster, Stefan, Berezowska, Sabina, Yao, Feng, Ochsenbein, Adrian F., Marti, Thomas M., Kocher, Gregor J., Schmid, Ralph A., Dorn, Patrick, Peng, Ren-Wang

Volltext

Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model von Schmid, Karin F, Zeinali, Soheila, Moser, Susanne K, Dubey, Christelle, Schneider, Sabine, Deng, Haibin, Haefliger, Simon, Marti, Thomas M, Guenat, Olivier T

Volltext

Translesion DNA synthesis in the context of cancer research von Knobel, Philip A, Marti, Thomas M

Volltext

DNA mismatch repair and mutation avoidance pathways von Marti, Thomas M., Kunz, Christophe, Fleck, Oliver

Volltext

Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy von Shi, Yandong, Felley-Bosco, Emanuela, Marti, Thomas M, Stahel, Rolf A

Volltext

Inhibition of REV3 Expression Induces Persistent DNA Damage and Growth Arrest in Cancer Cells von Knobel, Philip A, Kotov, Ilya N, Felley-Bosco, Emanuela, Stahel, Rolf A, Marti, Thomas M

Volltext